Levi & Korsinsky Reminds Merck & Co., Inc. Investors of the Pending Class Action Lawsuit with a Lead Plaintiff Deadline of April 14, 2025 - MRK
Portfolio Pulse from
Levi & Korsinsky law firm has filed a class action securities lawsuit against Merck & Co., alleging securities fraud related to Gardasil sales projections. The lawsuit claims Merck misrepresented expected revenue of $11 billion from Gardasil by 2030, particularly in the Chinese market. On February 4, 2025, Merck announced it would cease Gardasil shipments to China, causing the stock to drop over 9% in a single day.
March 28, 2025 | 2:45 pm
News sentiment analysis
Sort by:
Ascending
NEGATIVE IMPACT
The class action lawsuit alleges Merck misled investors about Gardasil sales projections in China, potentially impacting the company's financial credibility and stock performance.
The lawsuit directly targets Merck's representations about Gardasil sales, which caused a significant stock price drop and could lead to financial penalties and reputational damage.
CONFIDENCE 90
IMPORTANCE 85
RELEVANCE 100